Hedge fund investor Dan Niles unveils his top picks for 2024, including Amazon and Meta
Widely followed investor Dan Niles on Tuesday revealed his top stock picks for 2024, including one…
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new…
Health sector themes to watch in 2024
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech…
Trends don't run forever. These ETFs can be contrarian winners in 2024
While many of the 2024 outlooks coming from Wall Street shops are building toward a stock market…
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21…
Biotechs that could rally 35%+ include one targeting Schizophrenia
With new drug launches and product approvals on the horizon, some biotechnology stocks could finally…
Why you want to own ETFs ahead of this conference
Next week is one of the biggest of the year for health-care investors, and it has historically been…
Some stocks are 'summer rentals,' available to move in and move out
In volatile July, investors may be treating some stock market trades like ‘summer…